Skip to main content

Want a detailed portfolio tracker?

Precigen (PGEN) P/E (2013 - 2026)

Precigen (PGEN) P/E from Sep 30, 2013 to Jul 21, 2026. The TTM Precigen (PGEN) P/E is -9.36. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Precigen (PGEN)

YearP/EChange
2026-9.36+67.06%
2025-5.60+136.34%
2024-2.37-37.47%
2023-3.79-129.97%
202212.64-250.65%
2021-8.39-21.15%
2020-10.64+281.89%
2019-2.79-33.39%
2018-4.18-59.85%
2017-10.42-36.63%
2016-16.45-60.43%
2015-41.57+19.57%
2014-34.77-122.42%
2013155.03N/A

Comparison Precigen (PGEN) P/E with competitors

Precigen (PGEN) P/E is -9.36.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.80%
FGENFibroGen Inc0.24-102.56%
CHRSCoherus Biosciences Inc0.85-109.07%
FBIOFortress Biotech Inc0.95-110.14%
ORMPOramed Pharmaceuticals Inc1.50-116.06%
AGENAgenus Inc3.01-132.16%
INVAInnoviva Inc3.15-133.70%
VXRTVaxart Inc3.55-137.93%
CRMDCorMedix Inc3.63-138.77%
CVACCureVac N.V.4.45-147.50%
GLPGGalapagos NV4.86-151.92%
SRPTSarepta Therapeutics Inc4.88-152.17%
ABEOAbeona Therapeutics Inc5.39-157.57%
ABUSArbutus Biopharma Corp5.60-159.79%
ZVRAZevra Therapeutics Inc5.89-162.91%
SPROSpero Therapeutics Inc6.23-166.55%
CGENCompugen Ltd6.31-167.47%
RIGLRigel Pharmaceuticals6.87-173.43%
SLXNSilexion Therapeutics Corp7.30-177.96%
OMEROmeros Corporation9.26-198.93%
AUPHAurinia Pharmaceuticals Inc9.58-202.42%
PLXProtalix BioTherapeutics Inc10.89-216.38%
ACADAcadia Pharmaceuticals Inc11.73-225.33%
TBPHTheravance Biopharma Inc12.26-231.03%
ADMAAdma Biologics Inc12.42-232.69%
HRMYHarmony Biosciences Holdings Inc13.82-247.68%
SABSSAB Biotherapeutics Inc14.14-251.05%
NAGENiagen Bioscience Inc14.82-258.34%
INCYIncyte Corp15.82-269.07%
REGNRegeneron Pharmaceuticals Inc15.86-269.44%
PBYIPuma Biotechnology Inc17.32-285.03%
CPRXCatalyst Pharmaceuticals Inc17.44-286.35%
EXELExelixis Inc17.54-287.40%
TGTXTG Therapeutics Inc18.97-302.66%
MDXGMimedx Group Inc20.55-319.61%
XOMAXOMA Royalty Corp22.87-344.43%
ARGXArgen X SE24.30-359.64%
CTMXCytomX Therapeutics Inc24.82-365.23%
XOMAOXOMA Royalty Corp25.34-370.83%
HALOHalozyme Therapeutics Inc25.62-373.81%
XOMAPXOMA Royalty Corp25.67-374.31%
VRTXVertex Pharmaceuticals Inc27.99-399.15%
RPRXRoyalty Pharma plc - Class A28.69-406.55%
SLNOSoleno Therapeutics Inc29.02-410.05%
ASNDAscendis Pharma A/S30.09-421.49%
LGNDLigand Pharmaceuticals Inc - Class B37.91-505.12%
APLSApellis Pharmaceuticals Inc39.02-516.97%
BMRNBiomarin Pharmaceutical Inc42.21-551.07%
KRYSKrystal Biotech Inc45.34-584.53%
ONCBeiGene Ltd69.54-843.10%
PHARPharming Group N.V.75.03-901.71%
TECHBio-Techne Corp101.96-1189.51%
VCELVericel Corp109.92-1274.60%
ALNYAlnylam Pharmaceuticals Inc117.96-1360.55%
GMABGenmab140.29-1599.12%
TLXTelix Pharmaceuticals Ltd162.15-1832.74%
CORTCorcept Therapeutics Inc212.86-2374.56%